Embleema

Embleema

Created using Figma
Created using Figma

Ultimo aggiornamento

31 ott 2018

La tua storia medica è a prova di manomissione e sempre disponibile grazie alle funzionalità di sicurezza e distribuzione dei dati di Blockchain Scegli quali fornitori possono vedere quale parte della tua cartella clinica e sai esattamente chi ha effettuato l'accesso e quando La tua privacy è completamente protetta in un modo conforme a HIPAA
Rischio: molto alto
Private Sale
ott, 2018
mar, 2019
100% completato
Fondi raccolti - nessun dato
309
Obbiettivo 20 000 000.00 USD
berretto 2 000 000.00 USD
Hard cap 30 000 000.00 USD
past
  • 1 RWD
    =
    0.2 USD
Dettagli del token
telescrivente
RWD
Valute accettate
ETH, BTC, BCH, FIAT
Dettagli della Compagnia
Nome della società registrata
Embleema Inc
Paese registrato
United States, France
Società fondata
Jun 1, 2017
dettagli aggiuntivi
MVP / Prototipo
piattaforma
Ethereum
KYC
categorie
Salute

Di Embleema

Informazioni su Emblema

Riteniamo che la tecnologia Blockchain sia lo standard ideale in grado di fornire ai pazienti, agli operatori sanitari, ai pagatori e ai fornitori di assicurazione sanitaria una visione condivisa, completa, longitudinale e attendibile della storia medica del paziente. Se conservato come libro mastro delle transazioni, la storia medica del paziente è chiaramente accessibile a tutte le parti interessate con la dovuta autorizzazione da parte del paziente e può essere determinata la migliore opzione di trattamento.

PatientTruth & trade; è una soluzione software basata su Cloud e Blockchain che si collega alle diverse cartelle cliniche dei pazienti presso i vari centri di servizi sanitari, come ospedali, cure primarie, centri riabilitativi, case di cura e centri di cura urgenti, e li incatena in modo coerente, storia medica completa e a prova di manomissione. PatientTruth & trade; fornisce una visione olistica della storia medica di un paziente tra fornitori e centri di assistenza.

Caratteristiche

Patients can:

• Register and sign-on through the Patient Dapp interface,

• Upload their health records in the Blockchain, • Visualize their patient record,

• Authorize the sharing of their identified patient record to providers,

• Expose and sell their health records in the Marketplace against RWE tokens,

• Visualize a full audit-trail on their patient record access and health records sold,

• Visualize a statement of his/her RWE transactions.

 

Providers can:

• Register and sign-on through the Provider Dapp interface,

• Visualize an identified patient record, with due consent from the patient,

• Perform a health record quality check, when requested by the health record data owner,

• Visualize a statement of his/her RWE transactions,

 

Care Centers and other Data Owners can:

• Register and sign-on through the Data Owner Dapp interface,

• Have their health records indexed into the Blockchain and linked to patients,

• Expose and sell their health records in the Marketplace against RWE tokens, with due consent from the patients,

• Visualize a statement of RWE transactions,

 

Pharma companies, Payers and other Data Buyers can:

• Register and sign-on through the Data Buyer Dapp interface,

• Expose their inclusion criteria for health record purchases,

• Browse a list of data owners which own health records matching their inclusion criteria,

• Select the data owners they wish to purchase health records from,

• Execute the purchase in RWE tokens with data owners,

• Visualize a statement of RWE transactions,

 

Pharma companies and authorities can:

• Register and sign-on through the Real-World Evidence Dapp interface,

• Pharma companies register health products on which they wish to share with authorities Real-World Evidence, and define the patient records they wish to share,

• Authorities can visualize the shared Real-World Evidence from Pharma companies.

We expect Version 2 to be HIPAA compliant (see “Embleema and Privacy Compliance section” below) for the U.S. users and GDPR compliant for the European users. Version 2 will include health records from U.S. patients. Version 2 is planned to launch in Q3 2019.

Informazioni tecniche

Embleema Health Blockchain versione 2 contiene le seguenti funzionalità:


& bull; Contratti intelligenti specifici per il settore sanitario che gestiscono il consenso del paziente, archivio di cartelle cliniche, archiviazione e condivisione dei record dei pazienti (identificati e non identificati), percorso di controllo degli accessi ai record dei pazienti e il
Marketplace,
& bull; Token RWE incorporato generato dalla Blockchain per le commissioni di transazione
e altri premi. Le transazioni con token RWE non richiedono il pagamento di tariffe "gas" dal mittente e prevedono un tempo di mining prevedibile,
& bull; API e parser di record di integrità da integrare nel Blockchain
vari input di dati in formato per record sanitari come HL 7 FHIR, CCD
, formati di dispositivi connessi proprietari e altri formati di record sanitari
,
& bull; Scalabilità: fino a 2 milioni di pazienti per il mercato statunitense,
& bull; Prestazioni: la visualizzazione delle cartelle cliniche dovrebbe avvenire entro 2 secondi, l'estrazione nella Blockchain dovrebbe avvenire in meno di 5 secondi,
riconciliare gli acquirenti di dati con i criteri di inclusione dei proprietari di dati nel Marketplace dovrebbe avvenire in meno di 1 minuto , altre elaborazioni batch
come l'analisi e l'indicizzazione delle origini dati saranno valutate in termini di prestazioni per ciascuna origine dati.

Il contratto intelligente esposto ai partecipanti alla rete è:
& bull; Record sanitario: scrivi, leggi un record sanitario nella Blockchain,
& bull; Registrazione del paziente: collegare i record sanitari a un determinato paziente, leggere
il record del paziente da Blockchain,
& bull; Consenso del paziente: definisce l'autorizzazione del paziente a condividere i suoi registri sanitari (identificati e de-identificati),
& bull; Audit Trail: fornisce ai proprietari dei dati audit-trail sugli accessi
ai loro archivi sanitari,
& bull; Marketplace: espone i metadati dei record di integrità dei proprietari dei dati
dopo aver ricevuto l'autorizzazione dei pazienti, consente agli acquirenti di dati di cercare record sanitari per l'acquisto, confronta gli acquirenti di dati & rsquo; criteri di inclusione
con i record dei proprietari dei dati, esegue le transazioni di acquisto
tra acquirenti di dati e proprietari di dati,
& bull; Token token RWE: rilascia token RWE come ricompensa per i proprietari di dati
per la memorizzazione di record sanitari nella Blockchain (primi 3 anni)

% name% Roadmap

  • Embleema’s growth plan

  • Embleema has already launched the first patient Blockchain.

    Version 1 is publicly accessible at https://patienttruth.embleema.com
    and contains the following functionalities:
    • Upload HL7 Continuity of Care Documents (CCD) medical records
    into blockchain by patients (U.S. patients only),
    • Upload of Fitbit information into blockchain by patients,
    • Consolidation of CCDs (U.S. patients only) and Fitbit information
    into a Medical history stored securely on blockchain,
    • Authorization management from patients for the sharing of their
    Medical history with providers,
    • Visualization by providers of patients’ Medical histories after due
    authorization from patients,
    • Audit-trail for patients of Medical history accesses by providers,
    • Compensation to patients in EBL tokens for uploading CCDs
    (U.S. patients only) and Fitbit information, as well as referrals of
    new patients and providers.

    Version 1 will be used to pilot and prove in real-life the relevance of
    the 2 key concepts carried by the Embleema Health Blockchain:
    • Patients have control of their health records and may share and
    sell their data to pharma companies: this pilot will start in September
    2018 with cysticfibrosis.com, a U.S. based patient community in
    Cystic Fibrosis (announced on July 17, 2018: https://medcitynews.
    com/2018/07/embleema-emerges-from-stealth-mode-launchesblockchain-
    based-health-record-system/),
    • Pharma companies and regulators share the next generation of
    RWE: real-time, individual-patient level 360 view medical histories,
    with continuous monitoring of the same patient and his/her full
    and trusted consent: this pilot will start in January 2019 with
    a top-5 global pharma company and a leading health regulator
    (announcement planned in Q4 2018).
  • End of 2019

  • End of 2019, Embleema expects to expand its Blockchain to the French
    market and the China marketplace with its 800 million connected patient
    population by striking a set of strategic distribution partnerships with major
    local players in the healthcare and technology industry.
  • Q3 2019

  • Concurrently to its V2 launch in Q3 2019, Embleema plans to set up consulting
    services for pharmaceuticals and health network to facilitate the
    adoption of blockchain in their processes and systems.
  • 2021

  • In 2021, Embleema plans to launch V3 of its Health Blockchain Network
    which will able to integrate mining nodes from pharma companies, payers
    and care centers. V3 will also implement an API allowing third party patient
    app providers to connect to the Blockchain and offer personalized services
    to patients through the Blockchain.
  • Leggi di più
  • 2022

  • For 2022, with a critical mass of patient records stored onto the Blockchain,
    Embleema plans to offer advanced analytics services for various purposes:
    population health, observational studies, safety studies. Embleema will also
    start researching the possibility of offering predictive medicine services
    based on the wealth of data stored in the Blockchain.

Attività

Attività:
36
VERY LOW
Messaggi:
12
VERY LOW
Visualizzazioni:
450
VERY LOW
Attività:
36
VERY LOW
Merito:
0
VERY LOW
Messaggi:
12
VERY LOW
Visualizzazioni:
450
VERY LOW
utenti:
7
VERY LOW
Seguaci:
2 550
MEDIUM
tweets:
487
HIGH
Crescita di 30 giorni:
-1

Embleema Squadra

verificata 100%

Robert Chu
Founder, CEO and CTO
verificata
Prashant Khambekar,...
Chief Blockchain Development Executive
verificata
Pradeep Sreekanthan
Chief Delivery Officer
verificata
Vincent Galand
Manager, Operations
verificata
Pascal Becache
Business Development Executive
verificata
Nicolas Schmidt
Chief Product Officer
verificata
Alexis Normand
Head of Blockchain Consortium
verificata

Advisors

verificata 29%

Attenzione. C'è il rischio che i membri non verificati non siano effettivamente membri del team

Vahan Simonyan, PhD
Advisor | Chief Scientist - WHISE-Embleema Health...
non verificato
Frederic Duchesne, P...
Advisor | CEO of Pierre Fabre Pharmaceuticals
non verificato
Atakan Seçkin
Advisor | User Experience
verificata
Pr. John Halamka, MD
Advisor | Professor of Innovation at Harvard Medic...
non verificato
Adel Al-Saleh
Advisor | CEO of T-Systems and Board Member of Deu...
non verificato
Bernard Gilly, PhD
Advisor | CEO at GenSight Biologics & Chairman at...
non verificato
Lorenzo Nardiello
Social Media Manager
verificata

Embleema Interviste

Atakan Seçkin
As a team member, сan you tell us about your role in the ICO project?
Branding, UI/UX design and implementation of PatientTruth (since POC to product launch) ICO dashboard and future projects
What do you think about idea?
I've designed several products in healthcare industry prior to this project, and none of those projects placed the patient in the center - information asymmetry is a real problem. I believe blockchain with thoughtful design can enable patients to do so much more with their data - not only in terms of being aware, but also the control to choose who can see your data, and monetize it on your own terms and no one else's. We know we have a long road ahead, but I have confidence that we have the best team in the world to be making this product, and we can evolve it in a way that will disrupt existing industries.
Lorenzo Nardiello
As a team member, сan you tell us about your role in the ICO project?
I am in charge of the social media : Telegram, Bitcointalk, Reddit, Discord ... I also organize the bounty program that will come soon and manage our ambassador.
What do you think about idea?
Imagine a world in which you can contribute to medical research and create safer, less expensive and faster new treatments against cancer and rares diseases. Imagine a tamper-proof, holistic, longitudinal and patient-centric worldwide health record interfacing with medical researchers, health regulators, physicians, care centers and the pharmaceutical industry.
Robert Chu
As a team member, сan you tell us about your role in the ICO project?
Founder and CEO of Embleema
I am responsible for overall product strategy, go-to-market and sales of our Embleema Health Blockchain which was launched publicly in July 2018
What do you think about idea?
Embleema Health Blockchain helps patients to advance clinical research by securely sharing their data to pharmaceutical companies during real-world evidence and clinical trial studies. Pharmaceutical companies benefit from faster and more precise data which they can in turn share with regulators such as the U.S. Food and Drug Administration (FDA). Ultimately, patients receive innovative treatments sooner, this is the meaning of our work.
Prashant Khambekar, PhD
As a team member, сan you tell us about your role in the ICO project?
I handle the blockchain development. This includes the ICO/token part.

I also help determine the strategy of the company and its products.
What do you think about idea?
It is a wonderful idea whose time has come. Patients should have the right to control their own health data. The token mechanism helps maintain third-party oversight into the Embleema products.
Pradeep Sreekanthan
As a team member, сan you tell us about your role in the ICO project?
Delivering different versions of the platform. Making the customer experience delightful and easy. Working with various teams.
What do you think about idea?
Revolutionary - bringing healthcare to the blockchain is unusual and will be quite disruptive. RWE in particular.
Vincent Galand
As a team member, сan you tell us about your role in the ICO project?
I am Ops Manager at Embleema Inc. and run Embleema’s ICO operations, coordinating the team of technical experts, legal advisors, social media marketing manager and contractors around the project. I am also developping the business in Europe with pharma companies.
What do you think about idea?
I believe blockchain’s decentralisation power will disrupt the healthcare industry allowing everyone to participate to the advancement of medical progresses. Moreover, we developped a real, concrete industrial use case of Blockchain technology to accelerate medical research, e.g. Real World Evidence / Phase IV clinical trials. We are the only ICO project with a product already available on the market (PatientTruth), first major clients (Pierre Fabre, Servier, others coming soon) and a full support from the medical research community, the pharmaceutical industry and patient associations.
Pascal Becache
As a team member, сan you tell us about your role in the ICO project?
In France and Europe : Investors relations, business development, relations with Pharma companies. As a former IBM and IMS Health executive, I unveil the value of the patient data blockchain for investors, pharmaceutical companies, public and private health insurances and regulators.
What do you think about idea?
Embleema is the future of medical, drugs and population health studies. It will disintermediate collection and use of health data, allowing more, faster, cheaper and more ethical and transparent research benefiting to patients and healthcare systems. It complies with all regulatory aspects in the countries they enter.
Nicolas Schmidt
As a team member, сan you tell us about your role in the ICO project?
I'm Chief Product Officer at Embleema: I lead of our next product development, translate users and customers' needs into a world-class product and manage our marketing.
What do you think about idea?
We're the only healthcare project with a blockchain solution in production, valuable data on usage, several pharma companies as customers and a team of world-class advisors. We achieved all of this before launching our ICO in order to reduce risks for potential subscribers.
Alexis Normand
As a team member, сan you tell us about your role in the ICO project?
I bring together patient advocacy groups & life sciences researchers and regulatoirs to create a decentralized marketplace for health data, to replace the slow, manual and costly process of collecting real world evidence (RWE) for late stage clinical research
What do you think about idea?
Allowing patients to opt-in to pharma research along their own terms is game changing. Only blockchain allows patients to assemble the full picture of their health data, own and share it, and be compensated for their active involvement in clinical research.

Embleema Ultime novità

  • Poiché potrebbero esserci differenze temporali negli aggiornamenti delle informazioni, è necessario verificare le informazioni accurate su ciascun progetto ICO attraverso il suo sito web ufficiale o altri canali di comunicazione.
  • Questa informazione non è un suggerimento o consiglio su come investire in finanziamenti ICO. Si prega di indagare approfonditamente le informazioni rilevanti da soli e decidere sulla partecipazione ICO.
  • Se pensi che ci siano problemi o problemi da correggere su questo contenuto, o se desideri inviare il tuo progetto ICO da elencare, per favore inviaci un'email.
Si prega di leggere la dichiarazione di non responsabilità e l'avviso di rischio. Mostra disclaimer e avviso di rischio.
Planning an ICO? We can help with a wide range of support for all stages of your ICO